Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD300c antibody (AA 21-130)

The Mouse Monoclonal anti-CD300c antibody (Clone 2A10) (ABIN564723) specifically detects CD300c in ELISA. The antibody is reactive with Human samples.
Catalog No. ABIN564723
-15% Promotion 2026
$442.13
$520.15
save $78.02 (-15 %)
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 11 to 12 Business Days

Quick Overview for CD300c antibody (AA 21-130) (ABIN564723)

Target

See all CD300c (CD300C) Antibodies
CD300c (CD300C)

Reactivity

  • 30
  • 2
  • 1
Human

Host

  • 22
  • 8
Mouse

Clonality

  • 25
  • 5
Monoclonal

Conjugate

  • 22
  • 2
  • 2
  • 2
  • 1
  • 1
This CD300c antibody is un-conjugated

Application

  • 23
  • 14
  • 5
  • 4
  • 2
  • 2
ELISA

Clone

2A10
  • Binding Specificity

    • 8
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 21-130

    Purpose

    Mouse monoclonal antibody raised against a partial recombinant CD300C.

    Sequence

    GYFPLSHPMT VAGPVGGSLS VQCRYEKEHR TLNKFWCRPP QILRCDKIVE TKGSAGKRNG RVSIRDSPAN LSFTVTLENL TEEDAGTYWC GVDTPWLRDF HDPIVEVEVS

    Cross-Reactivity

    Human

    Characteristics

    Antibody Reactive Against Recombinant Protein.

    Immunogen

    CD300C (NP_006669, 21 a.a. ~ 130 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

    Isotype

    IgG2a
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Buffer

    In 1x PBS, pH 7.4

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Target

    CD300c (CD300C)

    Alternative Name

    CD300C

    Background

    Full Gene Name: CD300c molecule
    Synonyms: CMRF-35A,CMRF35,CMRF35A,CMRF35A1,IGSF16,LIR

    Gene ID

    10871

    NCBI Accession

    NM_006678
You are here:
Chat with us!